On the other hand, the synergy between cetuximab and celecoxib on tumor growth inhibition, induction of apoptosis, inhibition of EGFR activity and drug resistance have been described in head and neck cancer and other tumor types[18, 19]. Here, EGFR is linked to head and neck cancer.